Genetics of bronchopulmonary dysplasia in the age of genomics

Current Opinion in Pediatrics

Volumn 22, Issue 2, 2010, Pages 134-138

  Lavoie, Pascal M ^a   Dubé, Marie Pierre ^b,c  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b MONTREAL HEART INSTITUTE   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Bronchopulmonary dysplasia; Genetic association studies; Heredity; Premature infant; Pulmonary disease

Indexed keywords

MANNOSE BINDING LECTIN 2; MATRIX METALLOPROTEINASE 16; SURFACTANT PROTEIN B; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

CHROMOSOME 6; DISEASE PREDISPOSITION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOMICS; HUMAN; HUMAN GENOME; INNATE IMMUNITY; LUNG DYSPLASIA; MICROSATELLITE MARKER; NEONATAL RESPIRATORY DISTRESS SYNDROME; NUCLEIC ACID BASE SUBSTITUTION; PEDIGREE ANALYSIS; PREMATURITY; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 77952257251     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOP.0b013e328336eb85     Document Type: Review

References (56)

1. Kinsella JP, Greenough A, Abman SH. Bronchopulmonary dysplasia. Lancet 2006;367:1421-1431.
2. Schmidt B, Asztalos EV, Roberts RS, et al. Impact of bronchopulmonary dysplasia, brain injury, and severe retinopathy on the outcome of extremely low-birth-weight infants at 18 months: results from the trial of indomethacin prophylaxis in preterms. J Am Med Assoc 2003;289:1124-1129. (Pubitemid 37430326)
3. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001;163:1723-1729. (Pubitemid 32578778)
4. Bhandari A, Bhandari V. Pitfalls, problems, and progress in bronchopulmonary dysplasia. Pediatrics 2009;123:1562-1573.
5. Stenson PD, Mort M, Ball EV, et al. The human gene mutation database: 2008 update. Genome Med 2009;1:13. The human gene mutation database constitutes the largest inventory of genetic variants. The database currently includes over 85 000 lesions detected in 3253 genes, accumulated through an international consortium of scientists. Reported entries include either disease-causing mutations or disease-associated polymorphisms, as well as some genetic polymorphisms that have clear physiological effects without necessarily having been associated with a specific human disease.
6. McCarroll SA, Kuruvilla FG, Korn JM, et al. Integrated detection and population-genetic analysis of SNPs and copy number variation. Nat Genet 2008;40:1166-1174.
7. Shendure J, Ji H. Next-generation DNA sequencing. Nat Biotechnol 2008;26:1135-1145.
8. Frazer KA, Ballinger DG, Cox DR, et al. A second generation human haplotype map of over 3.1 million SNPs. Nature 2007;449:851-861.
9. Johnson GC, Esposito L, Barratt BJ, et al. Haplotype tagging for the identification of common disease genes. Nat Genet 2001;29:233-237. (Pubitemid 32952665)
10. Hindorff LA, Sethupathy P, Junkins HA, et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci USA 2009;106:9362-9367.
11. Altshuler D, Daly MJ, Lander ES. Genetic mapping in human disease. Science 2008;322:881-888.
12. Pe'er I, Yelensky R, Altshuler D, Daly MJ. Estimation of the multiple testing burden for genomewide association studies of nearly all common variants. Genet Epidemiol 2008;32:381-385. (Pubitemid 351656309)
13. Gao X, Starmer J, Martin ER. A multiple testing correction method for genetic association studies using correlated single nucleotide polymorphisms. Genet Epidemiol 2008;32:361-369. (Pubitemid 351656307)
14. Dudbridge F, Koeleman BP. Efficient computation of significance levels for multiple associations in large studies of correlated data, including genomewide association studies. Am J Hum Genet 2004;75:424-435. (Pubitemid 39095818)
15. Thomas D, Langholz B, Clayton D, et al. Empirical Bayes methods for testing associations with large numbers of candidate genes in the presence of environmental risk factors, with applications to HLA associations in IDDM. Ann Med 1992;24:387-392.
16. Zeggini E, Ioannidis JP. Meta-analysis in genome-wide association studies. Pharmacogenomics 2009;10:191-201.
17. Chauhan M, Bombell S, McGuire W. Tumour necrosis factor (-308A) poly-morphism in very preterm infants with broncho-pulmonary dysplasia: metaanalysis. Arch Dis Child Fetal Neonatal Ed 2009; 94: F257-F259. This is a well conducted meta-analysis and largest study reporting a genetic association with BPD. Associations with nucleotide substitutions at position-308 in the TNF-αgene did not remain significant after studies were combined.
18. Avery ME, Tooley WH, Keller JB, et al. Is chronic lung disease in low birth weight infants preventable? A survey of eight centers. Pediatrics 1987;79:26-30. (Pubitemid 17060953)
19. Horbar JD, McAuliffe TL, Adler SM, et al. Variability in 28-day outcomes for very low birth weight infants: an analysis of 11 neonatal intensive care units. Pediatrics 1988;82:554-559.
20. Parker RA, Lindstrom DP, Cotton RB. Evidence from twin study implies possible genetic susceptibility to bronchopulmonary dysplasia. Semin Perinatol 1996;20:206-209.
21. Bhandari V, Bizzarro MJ, Shetty A, et al. Familial and genetic susceptibility to major neonatal morbidities in preterm twins. Pediatrics 2006;117:1901-1906. (Pubitemid 46071232)
22. Lavoie PM, Pham C, Jang KL. Heritability of bronchopulmonary dysplasia, defined according to the consensus statement of the national institutes of health. Pediatrics 2008;122:479-485. Classic twin analyses confirmed the substantial (>79%) genetic contribution to BPD susceptibility, as well as to persistence of the ductus arteriosus. The conclusion is strengthened by the use of two validated case BPD definitions, including the National Institute of Child Health and Human Development consensus definition. In this study population, mild BPD, which generally has low longterm prognostic value, was mainly attributable to shared environmental effects. In contrast, moderate or severe BPD was attributable to strong genetic factors and therefore indicates a valid outcome to use in genetic association studies.
23. Lauterbach R, Szymura-Oleksiak J, Pawlik D, et al. Nebulized pentoxifylline for prevention of bronchopulmonary dysplasia in very low birth weight infants: a pilot clinical study. J Matern Fetal Neonatal Med 2006;19:433-438. (Pubitemid 44272918)
24. Wilson AG, Symons JA, McDowell TL, et al. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci U S A 1997;94:3195-3199. (Pubitemid 27157287)
25. Kaluza W, Reuss E, Grossmann S, et al. Different transcriptional activity and in vitro TNF-αlpha production in psoriasis patients carrying the TNF-αlpha 238A promoter polymorphism. J Invest Dermatol 2000;114:1180-1183. (Pubitemid 30415236)
26. Kazzi SN, Kim UO, Quasney MW, Buhimschi I. Polymorphism of tumor necrosis factor-alpha and risk and severity of bronchopulmonary dysplasia among very low birth weight infants. Pediatrics 2004; 114: e243-e248.
27. Strassberg SS, Cristea IA, Qian D, Parton LA. Single nucleotide polymorphisms of tumor necrosis factor-alpha and the susceptibility to bronchopulmonary dysplasia. Pediatr Pulmonol 2007;42:29-36. (Pubitemid 46080150)
28. Lee K, Whalen M, Speert D, et al. Single Nucleotide Polymorphism in the Tumor Necrosis alpha (TNF-α) gene promoter and severity of bronchopulmonary dysplasia in preterm infants. In 2009 Pediatric Academic Societies' Annual Meeting May 2009;Baltimore, US: 2009: Poster presentation;Abstract #751359.
29. Hallman M, Haataja R. Surfactant protein polymorphisms and neonatal lung disease. Semin Perinatol 2006;30:350-361. (Pubitemid 44827228)
30. Rova M, Haataja R, Marttila R, et al. Data mining and multiparameter analysis of lung surfactant protein genes in bronchopulmonary dysplasia. Hum Mol Genet 2004;13:1095-1104. (Pubitemid 38786992)
31. Lin Z, Thomas NJ, Wang Y, et al. Deletions within a CA-repeat-rich region of intron 4 of the human SP-B gene affect mRNA splicing. Biochem J 2005;389:403-412. (Pubitemid 41021144)
32. Pavlovic J, Papagaroufalis C, Xanthou M, et al. Genetic variants of surfactant proteins A, B, C, and D in bronchopulmonary dysplasia. Dis Markers 2006;22:277-291. (Pubitemid 46333635)
33. Manar MH, Brown MR, Gauthier TW, Brown LA. Association of glutathione-S-transferase-P1 (GST-P1) polymorphisms with bronchopulmonary dysplasia. J Perinatol 2004;24:30-35. (Pubitemid 38159800)
34. Casanova JL, Abel L. Human mannose-binding lectin in immunity: friend, foe, or both? J Exp Med 2004;199:1295-1299.
35. Capoluongo E, Vento G, Rocchetti S, et al. Mannose-binding lectin polymorphisms and pulmonary outcome in premature neonates: a pilot study. Intensive Care Med 2007;33:1787-1794. (Pubitemid 47476661)
36. Hilgendorff A, Heidinger K, Pfeiffer A, et al. Association of polymorphisms in the mannose-binding lectin gene and pulmonary morbidity in preterm infants. Genes Immun 2007;8:671-677. (Pubitemid 350238437)
37. Agbeko RS, Peters MJ. Mannose-binding lectin and pulmonary morbidity in premature infants. Intensive Care Med 2008;34:777; author reply 778.
38. Thebaud B, Ladha F, Michelakis ED, et al. Vascular endothelial growth factor gene therapy increases survival, promotes lung angiogenesis, and prevents alveolar damage in hyperoxia-induced lung injury: evidence that angiogenesis participates in alveolarization. Circulation 2005;112:2477-2486. (Pubitemid 41504498)
39. Kwinta P, Bik-Multanowski M, Mitkowska Z, et al. Genetic risk factors of bronchopulmonary dysplasia. Pediatr Res 2008;64:682-688.
40. Hadchouel A, Decobert F, Franco-Montoya ML, et al. Matrix metalloproteinase gene polymorphisms and bronchopulmonary dysplasia: identification of MMP16 as a new player in lung development. PLoS ONE 2008; 3: e3188.
41. Danan C, Jarreau PH, Franco ML, et al. Gelatinase activities in the airways of premature infants and development of bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol 2002; 283: L1086-L1093. (Pubitemid 35204901)
42. Hartel C, Konig I, Koster S, et al. Genetic polymorphisms of hemostasis genes and primary outcome of very low birth weight infants. Pediatrics 2006;118:683-689. (Pubitemid 46085425)
43. Atac FB, Ince DA, Verdi H, et al. Lack of association between FXIII-Val34Leu, FVII-323 del/ins, and transforming growth factor beta1 (915G/T) gene polymorphisms and bronchopulmonary dysplasia (a single-center study). DNA Cell Biol 2009;29:13-18.
44. Kazzi SN, Quasney MW. Deletion allele of angiotensin-converting enzyme is associated with increased risk and severity of bronchopulmonary dysplasia. J Pediatr 2005;147:818-822.
45. Yanamandra K, Loggins J, Baier RJ. The angiotensin converting enzyme insertion/deletion polymorphism is not associated with an increased risk of death or bronchopulmonary dysplasia in ventilated very low birth weight infants. BMC Pediatr 2004;4:26. (Pubitemid 40177063)
46. Bokodi G, Derzbach L, Banyasz I, et al. Association of interferon gamma T+874A and interleukin 12 p40 promoter CTCTAA/GC polymorphism with the need for respiratory support and perinatal complications in low birthweight neonates. Arch Dis Child Fetal Neonatal Ed 2007; 92: F25-F29. (Pubitemid 46132962)
47. Concolino P, Capoluongo E, Santonocito C, et al. Genetic analysis of the dystroglycan gene in bronchopulmonary dysplasia affected premature Newborns. Clin Chim Acta 2007;378:164-167. (Pubitemid 46251529)
48. Conrad DF, Jakobsson M, Coop G, et al. A worldwide survey of haplotype variation and linkage disequilibrium in the human genome. Nat Genet 2006;38:1251-1260. (Pubitemid 44646287)
49. Spielman RS, Ewens WJ. The TDT and other family-based tests for linkage disequilibrium and association. Am J Hum Genet 1996;59:983-989.
50. Price AL, Patterson NJ, Plenge RM, et al. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 2006;38:904-909. (Pubitemid 44141658)
51. Bacanu SA, Devlin B, Roeder K. The power of genomic control. Am J Hum Genet 2000;66:1933-1944. (Pubitemid 30480100)
52. Gao X, Starmer J. Human population structure detection via multilocus genotype clustering. BMC Genet 2007;8:34.
53. Satten GA, Flanders WD, Yang Q. Accounting for unmeasured population substructure in case-control studies of genetic association using a novel latent-class model. Am J Hum Genet 2001;68:466-477. (Pubitemid 32147815)
54. Igl BW, Konig IR, Ziegler A. What do we mean by 'replication' and 'validation' in genome-wide association studies? Hum Hered 2009;67:66-68.
55. Hirschhorn JN. Genomewide association studies: illuminating biologic pathways. N Engl J Med 2009;360:1699-1701.
56. Doyle LW, Halliday HL, Ehrenkranz RA, et al. Impact of postnatal systemic corticosteroids on mortality and cerebral palsy in preterm infants: effect modification by risk for chronic lung disease. Pediatrics 2005;115:655-661.